Nimodipine BP/USP represents a high-purity calcium channel blocker specifically engineered for cerebral vasodilation applications in pharmaceutical manufacturing. This yellow cryst...

Nimodipine BP/USP represents a high-purity calcium channel blocker specifically engineered for cerebral vasodilation applications in pharmaceutical manufacturing. This yellow crystalline powder, chemically designated as 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-Pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl ester, demonstrates exceptional solubility in alcohol, chloroform, and ethyl acetate while remaining insoluble in water. With a consistent melting point of 123-126°C, our pharmaceutical-grade Nimodipine ensures reliable performance throughout formulation processes. Manufactured under stringent quality controls, this API delivers predictable therapeutic effects for critical neurological interventions where consistency and purity are non-negotiable.

The pharmaceutical industry utilizes Nimodipine primarily within neurology and critical care medicine sectors. Hospital pharmacies and compounding facilities incorporate this API into standardized treatment protocols for subarachnoid hemorrhage patients, where timing and efficacy directly impact recovery outcomes. Neurosurgeons and intensivists depend on Nimodipine's selective cerebral vasodilation properties to prevent secondary ischemic injuries following bleeding events. Global pharmaceutical manufacturers trust this BP/USP compliant ingredient for producing neuroprotective medications that meet international regulatory standards across multiple markets, ensuring patient safety and treatment effectiveness.

Businesses selecting our Nimodipine benefit from unmatched reliability and supply chain consistency that supports continuous production schedules. Our manufacturing partners receive comprehensive documentation and regulatory support that facilitates smooth market entry across multiple regions. The product's proven stability profile reduces formulation challenges while maintaining therapeutic efficacy throughout shelf life, providing cost-effective manufacturing solutions. Distributors appreciate the consistent quality that builds trust with medical professionals who depend on this critical medication for patient care in emergency situations.

Key Features:
- BP and USP compliance for global market access
- High purity yellow crystalline powder formulation
- Melting point consistently between 123-126°C
- Soluble in alcohol, chloroform and ethyl acetate
- Stable chemical properties for reliable manufacturing

Benefits:
- Consistent quality for predictable therapeutic outcomes
- Global regulatory compliance simplifies market entry
- Reliable performance in various dosage formulations
- Proven stability reduces manufacturing challenges
- Trusted by medical professionals for critical care